Ipratropium

證據等級: L1 | 預測適應症: 10


## 藥師評估報告

Ipratropium:從 阻塞性呼吸道疾病 到 阻塞性肺疾病

一句話總結

Ipratropium(溴化伊普托品)是一種抗膽鹼支氣管擴張劑,用於慢性阻塞性肺疾病和支氣管氣喘的治療。TxGNN 模型預測它對**阻塞性肺疾病 (obstructive lung disease)** 有潛在治療效果,目前有超過 **40 項臨床試驗**支持此預測,證據等級極高。

快速總覽

項目 內容
原適應症 慢性阻塞性支氣管炎、支氣管氣喘、阻塞性呼吸道疾病併發的可逆性支氣管痙攣
預測新適應症 bronchitis、obstructive lung disease、nasal cavity disease、pharyngitis、acute laryngopharyngitis、respiratory malformation、papillary conjunctivitis、pulmonary emphysema、Rienhoff syndrome、tracheal disease
TxGNN 預測分數 99.97%
證據等級 L1
台灣上市 已上市
許可證數 多張
建議決策 Validate

預測適應症詳細分析

1. obstructive lung disease L1 99.97% 主要分析

為什麼這個預測合理?

Ipratropium 是一種短效抗膽鹼劑,通過阻斷乙酰膽鹼對支氣管平滑肌 M3 受體的作用,產生支氣管擴張效果。其原適應症已涵蓋 COPD 和氣喘,預測的「阻塞性肺疾病」本質上與原適應症高度重疊。

</p>

此預測基於藥物的作用機轉,與現有臨床證據方向一致。

臨床試驗

試驗編號階段狀態人數主要發現
NCT00371527NACOMPLETED200Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Di...
NCT00668408PHASE4UNKNOWN1000Long-Term Oxygen Therapy (LTOT) in Chronic Obstructive Pulmonary Disease (COPD) ...
NCT00583778NACOMPLETED141A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Tre...
NCT02260011PHASE2COMPLETED41A Single-Dose, Double Blind, Crossover Trial to Determinate the Comparability of...
NCT00239434PHASE3COMPLETED200Comparison of 18 mg of Tiotropium Inhalation Capsules Once Daily and Atrovent Me...
NCT00794157PHASE3COMPLETED347A 12-week Treatment, Multicenter, Randomized, Double-blind, Placebo-controlled, ...
NCT06211920NAUNKNOWN140Prehospital Use of Non-invasive Ventilation for Acute Respiratory Failure Due to...
NCT02576626PHASE4COMPLETED40The Effectiveness of Single Dose Ultibro Breezhaler (Indacaterol/Glycopyrronium)...
NCT02584738PHASE4UNKNOWN152Efficacy of Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Ast...
NCT01332461N/ACOMPLETED5677Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and ...
NCT03271905NAUNKNOWN10Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodi...
NCT02504801PHASE4UNKNOWN73Efficacy of Nebulized Pulmicort Respules on Post Operation Pulmonary Complicatio...
NCT00928746PHASE3COMPLETED142ATROVENT HFA Actuation Indicator Open-Label Study in Adults With Chronic Obstruc...
NCT02232594N/ACOMPLETED834Postmarketing Surveillance Study (as Per § 67 (6) AMG [German Drug Law]) of Bero...
NCT05183841NAUNKNOWN40Effect of Bronchodilators on the Exercise Capacity of Bronchiectasis Patients
NCT02542254PHASE2COMPLETED36A Phase II, Randomised, Double Blind, Placebo Controlled, Six Way Crossover Stud...
NCT03611777N/ACOMPLETED901Non-interventional, Cross-sectional, Multicenter Study to Describe the Exacerbat...
NCT00922350NACOMPLETED59Heliox and Posture Optimize Action of Nebulization With Bronchodilators for Asth...
NCT00685841PHASE3COMPLETED717A Double-Blind, Double-Dummy, Randomized, Placebo- and Active-Controlled, Multic...
NCT02509299NACOMPLETED49Effect of Different Physiotherapy Treatments in Hospitalized COPD Patients
NCT00250679PHASE3COMPLETED443Multicenter, Double-Blind, Double-Dummy, Randomized, Active-Controlled, Parallel...
NCT02782052PHASE3WITHDRAWN0Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertensi...
NCT01072448PHASE3COMPLETED323A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled,...
NCT01636726N/ACOMPLETED1WEUKBRE5554: IMI PROTECT (Work Package 2): Use of Long Acting beta2 Adrenoceptor...
NCT01796730PHASE4COMPLETED60A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Random...
NCT05786950NACOMPLETED44Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease
NCT00674817PHASE2COMPLETED45A Randomized, Double-blind, Crossover Study to Investigate the Bronchodilatation...
NCT01696214PHASE4COMPLETED20SAPS:Smoking Asthmatics Pilot Study:
NCT02172469PHASE3COMPLETED215A Comparison of 18 µg of Tiotropium Inhalation Capsules and Atrovent® Metered Do...
NCT01089127PHASE3COMPLETED552A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Stu...
NCT02236182PHASE2COMPLETED57A Double-blind, Placebo Controlled Trial to Assess the Safety of Two-week Admini...
NCT01636713PHASE3COMPLETED581A 24-week Randomised, Double-blind and Placebo-controlled Study to Evaluate the ...
NCT00274066PHASE3COMPLETED65The Acute Bronchodilator Effects of a Single Dose (2 Puffs) of the Shortacting A...
NCT01336608PHASE3COMPLETED446A 24-week Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol 100/25 ...
NCT01778062PHASE3COMPLETED136A Phase Ⅲb, Multicenter, Double-blind, Randomized, Controlled Trial, to Assess t...
NCT03064113PHASE2COMPLETED32A Phase 2, Randomized, Double-Blind, Crossover Study to Examine the Pharmacodyna...
NCT00200967PHASE3COMPLETED87Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Respons...
NCT01714401NACOMPLETED50The Development of Procedures to Optimalize the Intensive Care Units Patients Cl...
NCT00900731PHASE3COMPLETED1598A 12-week Treatment, Multicenter, Randomized, Parallel-group, Blinded, Double-du...
NCT01331694N/ACOMPLETED76130Outcomes and Costs Associated With Initiating Maintenance Treatment With Flutica...
NCT03219866PHASE4TERMINATED40Preliminary Study for Comparison of Triple Therapy Nebulizer Versus Dry Powdered...
NCT02238158N/ACOMPLETED595Postmarketing Surveillance (as Per §67(6)AMG [German Drug Law]) of Atrovent® in ...
NCT03219736NAWITHDRAWN0A Randomized Controlled Trial of Non-Invasive Positive Airway Pressure in the Pe...
NCT01243788PHASE4UNKNOWN450Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Ipratropium/Albutero...
NCT04446637PHASE3WITHDRAWN0Comparison of Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 m...
NCT00240435PHASE3COMPLETED491A Randomized, Double-blind, Double-dummy, Placebo- and Active-controlled, Parall...
NCT06918418PHASE4COMPLETED60Comparison of Salbutamol Alone and Salbutamol in Combination With Ipratropium Br...
NCT00202176PHASE4COMPLETED32The Effects of Bronchodilators on Exertional Dyspnea and Exercise Performance in...
NCT02177344PHASE3COMPLETED646A Six Month, Randomized, Double-blind (Within Formulation), Multiple Dose Trial ...
NCT02247856NACOMPLETED9IN VIVO ASSESSMENT OF RADIOLABELED AEROSOL DURING NONINVASIVE VENTILATION IN STA...

相關文獻

PMID年份類型期刊主要發現
356161262022ArticleThe Cochrane database of systeMagnesium sulfate for acute exacerbations of chronic obstructive pulmonary disea...
31556761985ArticleDrug intelligence & clinical pIpratropium bromide.
231700312012ArticleThe Annals of pharmacotherapyConcomitant use of ipratropium and tiotropium in chronic obstructive pulmonary d...
29771091988ArticleClinical pharmacyUse of ipratropium bromide in obstructive lung disease.
263919692015ArticleThe Cochrane database of systeTiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
105658791999ArticleRespiratory care clinics of NoAnticholinergic bronchodilators.
384575912024ArticleMedicineProbiotics combined with Budesonide and Ipratropium bromide for chronic obstruct...
29700091988ArticleThe New England journal of medIpratropium bromide.
240434332013ArticleThe Cochrane database of systeTiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
159872372005ArticleTreatments in respiratory mediIpratropium bromide HFA.
78132711995ArticleChestNonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive p...
25298031989ArticleThe American review of respiraLung Health Study.
201633242010ArticleExpert opinion on drug metabolInhaled albuterol/salbutamol and ipratropium bromide and their combination in th...
29518161986ArticleRespiration; international revControlled clinical study of a long-term treatment of chronic obstructive lung d...
98177081998ArticleAmerican journal of respiratorMeasurement of symptoms, lung hyperinflation, and endurance during exercise in c...
81813281994ArticleChestIn chronic obstructive pulmonary disease, a combination of ipratropium and albut...
166255432006ArticleThe Cochrane database of systeIpratropium bromide versus short acting beta-2 agonists for stable chronic obstr...
284612242017ArticleEBioMedicineResponsiveness to Ipratropium Bromide in Male and Female Patients with Mild to M...
18352911991ArticleThe American journal of mediciAcute bronchodilating effects of ipratropium bromide and theophylline in chronic...
168561132006ArticleThe Cochrane database of systeIpratropium bromide versus long-acting beta-2 agonists for stable chronic obstru...
</details>
2. nasal cavity disease L4 99.86%

相關文獻(1 篇)

PMID年份類型期刊主要發現
390476432024ArticleColloids and surfaces. B, BioiROS responsive hydrogel for inhibition of MUC5AC against allergic rhinitis: A ne...
3. pharyngitis L1 99.85%

臨床試驗(3 項)

試驗編號階段狀態人數主要發現
NCT05165992PHASE3UNKNOWN200Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19 (Ventanyl ...
NCT00845728PHASE3COMPLETED3439A Phase IIIb Multicenter, 52 Week Treatment, Randomized, Blinded, Double Dummy, ...
NCT02299375PHASE2COMPLETED184A Study to Evaluate the Efficacy and Safety of 15mg BID Losmapimod (GW856553) Co...

相關文獻(5 篇)

PMID年份類型期刊主要發現
358380142023ArticleThe LaryngoscopeIntranasal Anticholinergics for Treatment of Chronic Rhinitis: Systematic Review...
62179491982ArticleCurrent medical research and oA therapeutic comparison of ipratropium bromide and salbutamol in asthmatic pati...
350892022022ArticleMedicineNebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl ...
388797502024ArticleThe American journal of case rSinus Node Dysfunction Triggered by Tonsillar Abscess: Effects of Vagal Nerve Co...
150001202004ArticleConsumer reportsHow to choose a cold remedy.
4. acute laryngopharyngitis L5 99.84%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
5. respiratory malformation L1 99.80%

臨床試驗(12 項)

試驗編號階段狀態人數主要發現
NCT06964997N/AACTIVE_NOT_RECRUITING920Anisocoria in the ICU (AICU Study): Diagnostic Implications and Clinical Outcome...
NCT06110481N/ARECRUITING80Bronchodilator Response To Inhaled Beta-2 Agonist and Anticholinergic Drugs in C...
NCT00674817PHASE2COMPLETED45A Randomized, Double-blind, Crossover Study to Investigate the Bronchodilatation...
NCT00372112PHASE2COMPLETED68A 2-wk Study to Evaluate the Safety, Tolerability,Pharmacodynamics and Pharmacok...
NCT00180843NATERMINATED2Assessment of Ventilation-perfusion Abnormalities in Patients With Smoking-relat...
NCT01987219PHASE3COMPLETED15The Effects of Bronchodilator Therapy On Respiratory and Autonomic Function in P...
NCT00549679PHASE2COMPLETED104A Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety a...
NCT02299375PHASE2COMPLETED184A Study to Evaluate the Efficacy and Safety of 15mg BID Losmapimod (GW856553) Co...
NCT03170232PHASE2TERMINATED54A Randomized, Double-blind, Sponsor Open, Placebo-controlled, 52 Week Study Eval...
NCT00274040PHASE3COMPLETED141A Comparison of 18 μg of Tiotropium Inhalation Capsules and Atrovent Metered Dos...
NCT01316887PHASE3COMPLETED563A 52 Week Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 12...
NCT00000568PHASE3COMPLETEDN/ALung Health Study (LHS) I and III

相關文獻(13 篇)

PMID年份類型期刊主要發現
105154291999ArticleThe European respiratory journEffects of drugs on mucus clearance.
400694692025ArticleEuropean journal of pediatricsUnilateral mydriasis: an unexpected effect of ipratropium bromide inhalation-a b...
82967561994ArticleThe American journal of cardioAbnormalities of pulmonary function in patients with congestive heart failure, a...
271406772016ArticleRespirology (Carlton, Vic.)Bronchodilator responsiveness of peripheral airways in smokers with normal spiro...
40812771985ArticleRevue des maladies respiratoir[Pharmacology of mucociliary transport].
289325592017ArticleJournal of thoracic diseasePupillary abnormalities in non-selected critically ill patients: an observationa...
199118542009ArticleDrugsAcute severe asthma: new approaches to assessment and treatment.
190520542009ArticleThoraxEvaluation of acute bronchodilator reversibility in patients with symptoms of GO...
109761502000ArticleIndian heart journalPulmonary function profile in chronic congestive heart failure and the effect of...
100926901999ArticleThoraxRisk factors for death from asthma, chronic obstructive pulmonary disease, and c...
92307201997ArticleAmerican journal of respiratorInhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mi...
151010272004ArticleJournal of cardiac failureThe reversibility of increased airways resistance in chronic heart failure measu...
167867962005ArticlePrzeglad lekarski[A case of emphysema suggesting cystic lung disease in computer tomography].
6. papillary conjunctivitis L5 99.75%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
7. Rienhoff syndrome L5 99.69%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
8. tracheal disease L3 99.66%

臨床試驗(1 項)

試驗編號階段狀態人數主要發現
NCT04142814NAWITHDRAWN0Randomized Controlled Study on the Evaluation of the T-PEP Method Based on Posit...

相關文獻(16 篇)

PMID年份類型期刊主要發現
252782822015ArticleMedical principles and practicA comparative study of the beneficial effects of ipratropium and beclomethasone ...
357812342022ArticleTurkish archives of pediatricsThe Importance of Flexible Bronchoscopy in Difficult-to-treat Asthma from a Pedi...
376461252023ArticlePediatric pulmonologyDynamic computed tomography for evaluation of tracheobronchomalacia in premature...
236866922013ArticleJournal of pharmaceutical scieIn vivo evidence of organic cation transporter-mediated tracheal accumulation of...
124346492002ArticleRevista medica de Chile[Tracheobronchomalacia in pediatric patients: clinical experience].
305187992019ArticleJournal of perinatology : offiBronchoscopy in neonates with severe bronchopulmonary dysplasia in the NICU.
121333222002ArticleZhonghua jie he he hu xi za zh[Effect of ipratropium bromide on calcium activated potassium channel in trachea...
88396591996ArticleEuropean journal of clinical pAntimuscarinic effect of tiquizium bromide in vitro and in vivo.
298534892018ArticleThe European respiratory journThe mucus bundles responsible for airway cleaning are retained in cystic fibrosi...
91050951997ArticleAmerican journal of respiratorBronchial hyperreactivity in patients with familial amyloidotic polyneuropathy a...
183488872008ArticleEuropean journal of pharmacoloBronchodilatory effects of S-isopetasin, an antimuscarinic sesquiterpene of Peta...
244056922014ArticleBMC pulmonary medicinePharmacologic inhibition of S-nitrosoglutathione reductase protects against expe...
88665851996ArticleThe European respiratory journCholinergic control of rabbit tracheal transepithelial potential difference in v...
206584852010ArticlePediatric pulmonologyInhaled colistin for the treatment of tracheobronchitis and pneumonia in critica...
27143551989ArticleEuropean journal of pharmacoloMuscarinic stimulation of prostanoid synthesis by the isolated rat trachea: calc...
399020052025ArticleCureusA Rare Case of Endotracheal Metastases in Head and Neck Squamous Cell Carcinoma:...
9. anaphylaxis L4 99.38%

相關文獻(10 篇)

PMID年份類型期刊主要發現
300597912018ArticleAnnals of allergy, asthma & imManagement of anaphylaxis and allergies in patients with long QT syndrome: A rev...
84491201993ArticleChestAn unusual case of severe anaphylaxis due to ipratropium bromide inhalation.
128021492003ArticleThe American journal of nursinIt was a shock.
186277972008ArticleInternational immunopharmacoloValidation of guinea pig model of allergic rhinitis by oral and topical drugs.
61253981982ArticleEuropean journal of pharmacoloBronchodilator and antiallergic effects of thiazinamium chloride in guinea pigs,...
205973672010ArticleEksperimental'naia i kliniches[Antianaphylactic effects of muscarinic antagonists].
316263982020ArticlePediatric pulmonologyPrehospital management of pediatric asthma patients in a large emergency medical...
246827362014ArticleInvestigational new drugsSuccessful readministration of trastuzumab after severe immune reactions in two ...
70523391980ArticleBritish journal of pharmacologAtropine inhibits thromboxane A2 generation in isolated lungs of the guinea-pig.
25310661989ArticleChestSyncope caused by methacholine in a patient with exercise-induced anaphylaxis.
10. food-dependent exercise-induced anaphylaxis L5 99.36%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
## 台灣上市資訊 | 許可證號 | 品名 | 劑型 | 核准適應症 | |---------|------|------|-----------| | 多張許可證 | 溴化伊普托品 | 吸入劑/噴霧劑 | 慢性阻塞性支氣管炎、支氣管氣喘、慢性阻塞性肺疾 | ## 安全性考量 **常見副作用:** - 口乾 - 頭痛 - 咳嗽 - 噁心 **禁忌症:** - 對 atropine 或其衍生物過敏 - 閉角型青光眼 - 前列腺肥大伴尿滯留 **藥物交互作用:** - 與其他抗膽鹼藥物合用可能增加副作用 - Beta-2 激動劑:協同支氣管擴張效果 ### 藥物-疾病注意事項 (DDSI)
資料來源:DDInter 2.0(原文內容請參閱該網站)
**Anticholinergic Syndrome** 🟡 Moderate - 注意事項:Aclidinium, ipratropium, umeclidinium, and tiotropium are anticholinergic agents... **心搏過速** 🟡 Moderate - 需定期監測。 **Liver Failure** 🟡 Moderate - 應謹慎使用本藥物。 ## 結論與下一步 **決策:Validate** **理由:** TxGNN 預測的「阻塞性肺疾病」與 ipratropium 的核心適應症高度一致。超過 40 項臨床試驗提供了充分的療效和安全性證據。此預測更多是對現有適應症的確認和細化,而非真正的老藥新用發現。 **若要推進需要:** - 此藥物已被充分驗證用於阻塞性肺疾病 - 可直接參考現有臨床指引使用 - 無需額外驗證研究 --- ## 相關藥物報告 - [Docetaxel](/drugs/docetaxel/) - 證據等級 L1 - [Icatibant](/drugs/icatibant/) - 證據等級 L1 - [Naftifine](/drugs/naftifine/) - 證據等級 L1 - [Anastrozole](/drugs/anastrozole/) - 證據等級 L1 - [Temozolomide](/drugs/temozolomide/) - 證據等級 L1 ---
用 AI 幫我深入分析

想進一步了解這個藥物的老藥新用潛力嗎?點擊下方按鈕,直接開啟 AI 助手進行分析。

Claude:點擊後會複製提問並開啟新視窗,請按 Ctrl+V(Mac: Cmd+V)貼上
ChatGPT:點擊後直接開啟並自動帶入提問

## 引用本報告 如需引用本報告,請使用以下格式: **APA 格式:** ``` TwTxGNN. (2026). Ipratropium老藥新用驗證報告. https://twtxgnn.yao.care/drugs/ipratropium/ ``` **BibTeX 格式:** ```bibtex @misc{twtxgnn_ipratropium, title = {Ipratropium老藥新用驗證報告}, author = {TwTxGNN Team}, year = {2026}, url = {https://twtxgnn.yao.care/drugs/ipratropium/} } ``` ---
免責聲明
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。

最後審核:2026-02-20 | 審核者:TwTxGNN Research Team

討論與回饋

歡迎分享您對本報告的看法、補充資訊或提出問題。討論內容會同步到 GitHub Discussions。 需要 GitHub 帳號才能留言。


回到頂部

Copyright © 2026 Yao.Care. 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.